1. Home
  2. PRDO vs GENB Comparison

PRDO vs GENB Comparison

Compare PRDO & GENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perdoceo Education Corporation

PRDO

Perdoceo Education Corporation

SELL

Current Price

$31.86

Market Cap

2.0B

Sector

Real Estate

ML Signal

SELL

GENB

Generate Biomedicines Inc. Common Stock

N/A

Current Price

$13.78

Market Cap

1.9B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
PRDO
GENB
Founded
1994
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
1997
2026

Fundamental Metrics

Financial Performance
Metric
PRDO
GENB
Price
$31.86
$13.78
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $27.00
AVG Volume (30 Days)
508.6K
★ 1.1M
Earning Date
11-03-2026
11-03-2026
Dividend Yield
★ 2.16%
N/A
EPS Growth
★ 10.50
N/A
EPS
★ 1.60
N/A
Revenue
★ $581,296,000.00
N/A
Revenue This Year
$0.99
N/A
Revenue Next Year
$2.98
N/A
P/E Ratio
$19.70
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$26.66
$11.00
52 Week High
$38.50
$22.67

Technical Indicators

Market Signals
Indicator
PRDO
GENB
Relative Strength Index (RSI) 48.07 37.92
Support Level $31.45 $11.82
Resistance Level $32.79 $13.96
Average True Range (ATR) 1.00 0.91
MACD -0.01 -0.32
Stochastic Oscillator 57.74 9.29

Price Performance

Historical Comparison
PRDO
GENB

About PRDO Perdoceo Education Corporation

Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segments include the American InterContinental University, the University of St. Augustine for Health Sciences, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services, with the majority of the students enrolled in programs offered fully online. The majority of the its revenue comes from the Colorado Technical University segment.

About GENB Generate Biomedicines Inc. Common Stock

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Share on Social Networks: